Associate Professor Michael Back. EANO 2023 Abstract. - ViDoe

Associate Professor Michael Back. EANO 2023 Abstract.

173 views

The Brain Cancer Group, Care2Cure

1 year ago

Associate Professor Michael Back. EANO 2023 Abstract.

Associate Professor Michael Back. EANO 2023 Abstract.

Associate Professor Michael Back. EANO 2023 Abstract.

2:18

Associate Professor Michael Back. EANO 2023 Abstract.

by The Brain Cancer Group, Care2Cure

MSMilan2023 Abstract Winner - Ahmed Abdelhak

2:15

MSMilan2023 Abstract Winner - Ahmed Abdelhak

by ECTRIMS Congress

Muscle-invasive and metastatic bladder cancer: New EAU Guidelines update

16:22

Muscle-invasive and metastatic bladder cancer: New EAU Guidelines update

by European Association of Urology

New Approaches to Clinical Trials in Neuro Oncology by Mark Gilbert

27:23

New Approaches to Clinical Trials in Neuro Oncology by Mark Gilbert

by EANO

Prostatic artery embpolization- Non surgical treatment for prostatic problem

14:02

Prostatic artery embpolization- Non surgical treatment for prostatic problem

by Bankers vascular hospital (a unit of BnG vascular)

Troubleshooting VA ECMO in the Cardiac Surgery ICU

46:13

Troubleshooting VA ECMO in the Cardiac Surgery ICU

by Ahmed Hegazy

$2019 Final Round Yonsei University - HSBC\/HKU Asia Pacific Business Case Competition$

34:49

2019 Final Round Yonsei University - HSBC\/HKU Asia Pacific Business Case Competition

Why attend the EANS2023 Congress? Marike Broekman explains why!

1:04

Why attend the EANS2023 Congress? Marike Broekman explains why!

eEANO webinar on Nurses and Allied Health Professionals (AHP’s) in Neuro-Oncology

1:27:58

eEANO webinar on Nurses and Allied Health Professionals (AHP’s) in Neuro-Oncology

by EANO

B r u n a K a r l a 2024 MIX Best Songs Updated ~ Latin music

1:19:39

B r u n a K a r l a 2024 MIX Best Songs Updated ~ Latin music

by ALEX

Theravane: Overview EOC Guide

1:20

Theravane: Overview EOC Guide

TIDE-A: avelumab and intermittent axitinib in metastatic renal cell carcinoma

3:41

TIDE-A: avelumab and intermittent axitinib in metastatic renal cell carcinoma

The SHIVERS Symposium 2023 Panel with Dr Michael Baker

37:51

The SHIVERS Symposium 2023 Panel with Dr Michael Baker

#ANZUP23 ASM - Introducing CAP Member Michael Twycross

0:56

#ANZUP23 ASM - Introducing CAP Member Michael Twycross

by ANZUP Cancer Trials Group

International Vascular Cork(IVC) 2023

1:53

International Vascular Cork(IVC) 2023